Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

151.97
+2.241.50%
Post-market: 151.970.00000.00%19:14 EDT
Volume:1.07M
Turnover:162.63M
Market Cap:289.96B
PE:21.25
High:152.54
Open:151.55
Low:150.75
Close:149.73
52wk High:170.46
52wk Low:104.93
Shares:1.91B
Float Shares:1.82B
Volume Ratio:1.02
T/O Rate:0.06%
Dividend:4.67
Dividend Rate:3.07%
EPS(TTM):7.15
EPS(LYR):7.15
ROE:30.81%
ROA:11.14%
PB:6.29
PE(LYR):21.25

Loading ...

Dow Jones Top Company Headlines at 9 PM ET: Elon Musk's xAI Sued by NAACP Over Memphis Data Center | China-Backed ...

Dow Jones
·
Apr 15

Anthropic adds Novartis CEO Vas Narasimhan to its board

Reuters
·
Apr 14

Anthropic Appoints Novartis CEO Vas Narasimhan to Its Board

Deep News
·
Apr 14

Novartis Investors to Focus on Pipeline Update Amid Weak Results -- Market Talk

Dow Jones
·
Apr 10

Novartis to Expand Community Health Programs to More Countries

MT Newswires Live
·
Apr 09

AZN, NVO, NVS: What Does Trump’s New 100% Tariff Mean for Pharma Giants?

TIPRANKS
·
Apr 03

Trump Will Impose 100% Tariff on Some Patented Drugs

Tiger Newspress
·
Apr 03

Novartis Likely to Confirm Guidance -- Market Talk

Dow Jones
·
Apr 02

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Fresh Economic Data

MT Newswires Live
·
Mar 30

Novartis Says Drug Improves Kidney Function in Patients With Berger's Disease

MT Newswires Live
·
Mar 30

Global Equities Roundup: Market Talk

Dow Jones
·
Mar 30

Novartis to Take Earnings Hit From Generic Competition -- Market Talk

Dow Jones
·
Mar 30

Novartis announces two-year results from Phase III APPLAUSE-IgAN study

TIPRANKS
·
Mar 30

Novartis to buy biotech company Excellergy for up to $2B

TIPRANKS
·
Mar 27

Novartis (NVS) Stock Rises on $2B Excellergy Acquisition to Expand Allergy Portfolio

TIPRANKS
·
Mar 27

Novartis to Acquire US Biotech Firm Excellergy in Deal Worth Up to $2 Billion

Deep News
·
Mar 27

Novartis's Excellergy Payments Should Be Back-End Loaded -- Market Talk

Dow Jones
·
Mar 27

Novartis Acquires Excellergy for $2 Billion to Strengthen Food Allergy and Immune Disorder Portfolio

Stock News
·
Mar 27

Novartis to Acquire Excellergy For Up to $2 Billion

MT Newswires Live
·
Mar 27

Novartis Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Mar 27